PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.
about
Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the FateCD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor ActivityTherapeutic potential of chemokine signal inhibition for metastatic breast cancerRole of mesenchymal cells in the natural history of ovarian cancer: a reviewRegulation of immune responses by prostaglandin E2E-type prostanoid receptor 4 (EP4) in disease and therapyImmunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerRegulation of tumor metastasis by myeloid-derived suppressor cellsDynamic quantitative intravital imaging of glioblastoma progression reveals a lack of correlation between tumor growth and blood vessel densityThe Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer ProgressionMolecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic targetTherapeutic cancer vaccines and combination immunotherapies involving vaccinationChronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association ConsortiumMyeloid-derived suppressor cells: the dark knight or the joker in viral infections?Targeting Tumor Microenvironment: Effects of Chinese Herbal Formulae on Macrophage-Mediated Lung Cancer in Mice.Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal.Stromal reengineering to treat pancreas cancerStroma-derived Fibrinogen-like Protein 2 Activates Cancer-associated Fibroblasts to Promote Tumor Growth in Lung CancerThe role of chemoattractant receptors in shaping the tumor microenvironment.Regulation of COX2 expression in mouse mammary tumor cells controls bone metastasis and PGE2-induction of regulatory T cell migration.CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.Imaging CXCL12-CXCR4 signaling in ovarian cancer therapy.Molecular pathways: myeloid complicity in cancer.Myeloid-derived suppressor cells modulate immune responses independently of NADPH oxidase in the ovarian tumor microenvironment in mice.The intricate role of CXCR4 in cancer.Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction.Complexity and challenges in defining myeloid-derived suppressor cellsAberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancerMicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression.Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer.Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients.COX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cells.Transcriptional regulation of myeloid-derived suppressor cells.Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agentA phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer.Neural innervation stimulates splenic TFF2 to arrest myeloid cell expansion and cancer.
P2860
Q26777205-9C0B1ABC-F402-496F-94F2-2B0536FCE158Q26782520-9868EAFC-A8BB-4ADC-8FA2-5AABA945EEBDQ26798116-AA2F2011-90DB-4ABD-8A55-F3308089F03CQ26823555-BB136143-AA9A-4C50-9DC0-60803DE0D22AQ26849305-E9F34FBB-9C67-4BBC-B939-8B9571AC4933Q26851156-96D85E49-7778-4BF0-B4DB-4CFECDCCE62AQ26996829-F7449371-9B59-4E93-9F94-7D513AB0B7C7Q27022125-DF21D59B-FFB6-478E-A7A6-35762C4153C9Q27308856-D398E9A8-6C58-4E60-BCD6-5F691AE7D2DEQ28076760-CECB9073-CC82-4F2B-A455-BFA00587FCB6Q28393356-C221C4D8-BC76-4A8E-BD4A-45732CBBBD74Q28397609-2447FA61-F1F1-4C93-B808-96B6844E1818Q30276777-01904059-2404-4C66-AF7A-5C0A961BFF20Q30411008-526F70B7-EB1D-4B7E-AB78-00D65E1D8417Q33786852-79978D44-056A-4FC6-90EA-E5948B98F7B6Q33816141-B9CB5999-3B5D-4FCF-8EE3-72B0BAB3A059Q33827708-09DBF511-C17F-4E97-AC5A-7D8AFDCB7E85Q33837289-AC668B35-9FE7-434D-9802-F0597C7F4D0BQ33993124-A26B47C5-932C-4BFD-BB90-D3B5DBCBDA3EQ34431108-8AA5FEAF-7AE1-487C-B6F6-7079A5F2D89DQ34476278-6727ABEB-809E-4F7A-94B9-63F8278CED94Q34539323-4D9B1626-592B-49AD-8E9C-B04FA04319C5Q34570835-98F7CB9D-643A-4104-82EB-099F507F5AD1Q34725969-AC7E5545-2802-48D8-9AC5-138F5AFBD4C9Q34903354-334D96D9-6EB9-4FF2-9F62-B469F4B58812Q35067624-0F98A113-6E09-423E-9919-8534117DA566Q35169807-20AFF223-708A-4E85-B600-866BB56037CAQ35212274-50B2B29C-76E1-42A3-9628-CE24AEFBF75CQ35509317-BAFF06D2-F89C-4561-8D20-9C6A38B15D51Q35631181-CFFFA2E2-84E8-42EB-8C73-E58EEF9D5274Q35748965-9C1B3D7C-A859-44AB-A43E-6224C92D84D2Q35793791-A93F58EB-53AB-4918-8FE2-D8E6F38894E8Q35799695-3584E7F3-56F2-4143-941B-2092C09FA2F6Q35908928-482D89F2-5ED7-4E9D-8239-1A714F460372Q36060333-398F8050-557E-46B3-83D7-66CC10920C71Q36110362-307A70C5-FC2E-41A5-B58E-729EC624FEA1Q36322351-CFF9D0E7-8975-4FCD-A7C8-7B4D89CB6DA7Q36483712-7AC3AB97-2701-458A-86CB-F63F7ED9AB7BQ36544827-E43D7310-E114-42C9-BBEE-BDC9108D504AQ36549023-BACF9BBA-6FCE-44C8-A4DE-589CE587333F
P2860
PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PGE(2)-induced CXCL12 producti ...... in ovarian cancer environment.
@en
type
label
PGE(2)-induced CXCL12 producti ...... in ovarian cancer environment.
@en
prefLabel
PGE(2)-induced CXCL12 producti ...... in ovarian cancer environment.
@en
P2093
P2860
P1433
P1476
PGE(2)-induced CXCL12 producti ...... in ovarian cancer environment.
@en
P2093
Natasa Obermajer
Pawel Kalinski
Ravikumar Muthuswamy
Robert P Edwards
P2860
P304
P356
10.1158/0008-5472.CAN-11-2449
P407
P50
P577
2011-10-24T00:00:00Z